Cargando…
The next generation beneficial actions of novel probiotics as potential therapeutic targets and prediction tool for metabolic diseases
The prevalence of metabolic disease has rising and affected over 1,000 million populations globally. Since the metabolic disease and its related complication are board, it has become the major health hazard of modern world. However, Long term medication of metabolic disease may cause serious side ef...
Autores principales: | Cheng, Hsin-Lin, Yen, Gow-Chin, Huang, Shih-Chien, Chen, Shiuan-Chih, Hsu, Chin-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Food and Drug Administration
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931004/ https://www.ncbi.nlm.nih.gov/pubmed/35647717 http://dx.doi.org/10.38212/2224-6614.3396 |
Ejemplares similares
-
The potential role of phenolic compounds on modulating gut microbiota in obesity
por: Yen, Gow-Chin, et al.
Publicado: (2020) -
Next generation probiotics in disease amelioration
por: Chang, Chih-Jung, et al.
Publicado: (2019) -
Beneficial Bacteria Isolated from Food in Relation to the Next Generation of Probiotics
por: Sionek, Barbara, et al.
Publicado: (2023) -
Rutin and Gallic Acid Regulates Mitochondrial Functions via the SIRT1 Pathway in C2C12 Myotubes
por: Chang, Wei-Tang, et al.
Publicado: (2021) -
Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics
por: Yadav, Manoj Kumar, et al.
Publicado: (2022)